Help me fill in the blanks of the practice of ED Critical Care. In this podcast, we discuss all things related to the crashing, critically ill patient in the Emergency Department. Find the show notes at emcrit.org.
…
continue reading
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Ms Charise Gleason on Optimizing Patient Care
QUICKTIME•Episode home
Manage episode 504846945 series 1464173
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Featuring an interview with Ms Charise Gleason, including the following topics:
- Progress and change in the management of multiple myeloma (MM) (0:00)
- Patient- and disease-specific factors guiding therapeutic decision-making for newly diagnosed MM (5:11)
- Role of anti-CD38 antibodies in the management of MM (12:14)
- Emerging treatment options for smoldering myeloma (23:08)
- Optimizing long-term outcomes for patients with MM (25:38)
- Tailoring therapy for older adults and patients with preexisting comorbidities (29:59)
- Case: A woman in her early 80s with newly diagnosed transplant-ineligible MM who experienced a complete response with first-line daratumumab/lenalidomide and low-dose dexamethasone (34:34)
- Case: A man in his early 60s with progressive back pain from standard-risk MM who experienced a complete response with daratumumab with lenalidomide/bortezomib/dexamethasone (42:05)
- Building therapeutic relationships and integrating holistic care in oncology practice (47:13)
960 episodes
QUICKTIME•Episode home
Manage episode 504846945 series 1464173
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Featuring an interview with Ms Charise Gleason, including the following topics:
- Progress and change in the management of multiple myeloma (MM) (0:00)
- Patient- and disease-specific factors guiding therapeutic decision-making for newly diagnosed MM (5:11)
- Role of anti-CD38 antibodies in the management of MM (12:14)
- Emerging treatment options for smoldering myeloma (23:08)
- Optimizing long-term outcomes for patients with MM (25:38)
- Tailoring therapy for older adults and patients with preexisting comorbidities (29:59)
- Case: A woman in her early 80s with newly diagnosed transplant-ineligible MM who experienced a complete response with first-line daratumumab/lenalidomide and low-dose dexamethasone (34:34)
- Case: A man in his early 60s with progressive back pain from standard-risk MM who experienced a complete response with daratumumab with lenalidomide/bortezomib/dexamethasone (42:05)
- Building therapeutic relationships and integrating holistic care in oncology practice (47:13)
960 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.